AMRI (NASDAQ: AMRI) announced today that it will present and provide an
audio webcast of its corporate presentation at the UBS 2009 Global
Healthcare Services Conference on Tuesday, February 10, 2009.
AMRI Chief Executive Officer Thomas E. D’Ambra will present in a session
scheduled for 10:30 a.m. ET. The broadcast will be available to
investors and interested parties by accessing the company's website at www.amriglobal.com.
In addition, a replay of the webcast will be available for approximately
ninety days in the investor relations area of the company’s website at www.amriglobal.com/investor_relations.
Founded in 1991, AMRI provides scientific services, products and
technologies focused on improving the quality of life. AMRI works on
drug discovery and development projects and conducts manufacturing of
active ingredients and pharmaceutical intermediates for many of the
world’s leading healthcare companies. As an additional value added
service to its customers, the company is also investing in R&D in order
to expand it contract services and to identify novel early stage drug
candidates with the goal to outlicense to a strategic partner. With
locations in the U.S., Europe, and Asia, AMRI provides customers with a
wide range of services, technologies and cost models.